NDC 72000-320

SIVEXTRO

Tedizolid Phosphate

SIVEXTRO is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Nabriva Therapeutics Us, Inc.. The primary component is Tedizolid Phosphate.

• Product ID: 72000-320_2769a04d-5479-4341-93ca-ce9d323ada89
• NDC: 72000-320
• Product Type: Human Prescription Drug
• Proprietary Name: SIVEXTRO
• Generic Name: Tedizolid Phosphate
• Dosage Form: Injection, Powder, Lyophilized, For Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2014-06-20
• Marketing Category: NDA /
• Application Number: NDA205436
• Labeler Name: Nabriva Therapeutics US, Inc.
• Substance Name: TEDIZOLID PHOSPHATE
• Active Ingredient Strength: 200 mg/4mL
• Pharm Classes: Oxazolidinone Antibacterial [EPC],Oxazolidinones [CS],Breast Cancer Resistance Protein Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 72000-320-10

10 VIAL, GLASS in 1 CARTON (72000-320-10) > 4 mL in 1 VIAL, GLASS

• Marketing Start Date: 2014-06-20
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "SIVEXTRO" or generic name "Tedizolid Phosphate"

NDC	Brand Name	Generic Name
67919-040	SIVEXTRO	tedizolid phosphate
67919-041	SIVEXTRO	tedizolid phosphate
72000-310	SIVEXTRO	tedizolid phosphate
72000-320	SIVEXTRO	tedizolid phosphate